Coil treatment for migraine prevention study
Part of Brain & nervous system clinical trials.
This trial tests a treatment that places small coils in an artery behind the ear to reduce migraine days. It might be an option if you have tried at least two preventive medications without success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with migraine (with or without aura) and have 8 or more headache days per month.
- You have tried at least 2 different types of migraine preventive medications that did not work well enough.
- You are able to fill out an electronic headache diary and surveys.
- You do not have a different cause for your headaches (like a secondary headache disorder).
- You have not had this same artery coil procedure before and are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who undergo a procedure called middle meningeal artery embolization—a minimally invasive treatment that blocks blood flow to a specific artery thought to trigger migraines. The trial simply tracks your symptoms and quality of life before and after the procedure to understand how well it works.
This study tests a procedure called MMA embolization (blocking a small artery in the head) to see if it can reduce migraine attacks in people with chronic, hard-to-treat migraines.
This trial tests a procedure called bilateral middle meningeal artery embolization to see if it reduces chronic migraine symptoms in people who haven't found relief from other treatments. It's for those with frequent, disabling migraines that affect both sides of the head.
This study tests a type of magnetic brain stimulation (repetitive TMS) given daily at home to prevent migraines. It may be an option if your migraine medications aren't enough or you want a non-drug treatment.
This study tests whether repetitive transcranial magnetic stimulation (rTMS) — a noninvasive treatment using magnetic pulses on the head — can help prevent and treat chronic migraine pain. It may be an option for people who have never tried or are currently off migraine prevention medicines.
This study looks at how preventive treatments (botulinum toxin type A or anti-CGRP antibodies) affect thinking, memory, and quality of life in adults with hard-to-treat migraines. It aims to see if these treatments help more than just reducing headache days.
Hear when a new Migraine Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.